Oric Pharmaceuticals (ORIC) Enterprise Value (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Enterprise Value of -$281.9 million for Q1 2026, little changed on a QoQ basis from -$281.5 million in Q4 2025, and down 38.39% year-over-year from -$457.6 million in Q1 2025.
Oric Pharmaceuticals (ORIC) Enterprise Value (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Enterprise Value history runs 8 years deep, the most recent figure standing at -$281.9 million for Q1 2026.
- Quarterly Enterprise Value fell 38.39% year-over-year to -$281.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$281.9 million (down 38.39% YoY) and the FY2025 annual result came in at -$281.5 million, down 9.97% from the prior year.
- Enterprise Value was -$281.9 million for Q1 2026 at Oric Pharmaceuticals, roughly flat from -$281.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$189.6 million in Q1 2023 and bottomed at -$316.8 million in Q1 2024.
- A 5-year average of -$248.2 million and a median of -$256.0 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value tumbled 67.05% — and 2025, when it jumped 35.69%.
- Oric Pharmaceuticals' Enterprise Value stood at -$206.3 million in 2022, then retreated by 0.93% to -$208.2 million in 2023, then slipped by 22.95% to -$256.0 million in 2024, then dropped by 9.97% to -$281.5 million in 2025, then declined by 0.16% to -$281.9 million in 2026.
- Business Quant data shows ORIC's Enterprise Value at -$281.9 million in Q1 2026, -$281.5 million in Q4 2025, and -$287.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - | -281.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -281.93 Mn |
| Dec 31, 2025 | -281.49 Mn |
| Sep 30, 2025 | -287.14 Mn |
| Jun 30, 2025 | -282.51 Mn |
| Mar 31, 2025 | -203.72 Mn |
| Dec 31, 2024 | -255.96 Mn |
| Sep 30, 2024 | -272.37 Mn |
| Jun 30, 2024 | -286.41 Mn |
| Mar 31, 2024 | -316.78 Mn |
| Dec 31, 2023 | -208.19 Mn |
| Sep 30, 2023 | -227.30 Mn |
| Jun 30, 2023 | -264.16 Mn |
| Mar 31, 2023 | -189.63 Mn |
| Dec 31, 2022 | -206.27 Mn |
| Sep 30, 2022 | -193.66 Mn |
| Jun 30, 2022 | -227.06 Mn |
| Mar 31, 2022 | -234.62 Mn |
| Dec 31, 2021 | -236.98 Mn |
| Sep 30, 2021 | -289.52 Mn |
| Jun 30, 2021 | -261.07 Mn |